Quick Answer
Chemomab Therapeutics Ltd. reported Shares Outstanding of 37.10 million shares for fiscal year 2020.
Chemomab Therapeutics Ltd. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2020 | 37.10M | +0.0% |
| 2019 | 37.10M | +138.2% |
| 2018 | 15.58M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| March 31, 2023 | 232.64M | +2.0% | +0.0% |
| December 31, 2022 | 232.64M | +2.0% | +1.6% |
| September 30, 2022 | 229.02M | +0.5% | +0.2% |
| June 30, 2022 | 228.63M | +0.3% | +0.2% |
| March 31, 2022 | 228.09M | +6.6% | +0.0% |
| December 31, 2021 | 228.09M | +2359.2% | +0.1% |
| September 30, 2021 | 227.96M | +514.4% | +0.0% |
| June 30, 2021 | 227.96M | +514.4% | +6.5% |
- Chemomab Therapeutics Ltd. showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2018–2020 period, Chemomab Therapeutics Ltd.’s shares outstanding has grown by 138.2% (from 15.58 million shares to 37.10 million shares).
- The most recent figure is from Chemomab Therapeutics Ltd.’s fiscal year 2020 report (Form 10-K), filed with the SEC on March 9, 2021.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: